Literature DB >> 23438040

Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants.

Mélanie Vallin1, Nathalie Sturm, Géraldine Lamblin, Olivier Guillaud, Marie-Noëlle Hilleret, Valérie Hervieu, Juliette Joubert, Armand Abergel, Vincent Leroy, Olivier Boillot, Jérôme Dumortier, Jean-Yves Scoazec.   

Abstract

Liver cirrhosis is a recognized risk factor for intrahepatic cholangiocarcinoma (I-CCa). Small I-CCa nodules might be undiagnosed or misdiagnosed as hepatocellular carcinoma (HCC) in the context of liver cirrhosis. The aim of this study was to determine the prevalence and clinical impact of undetected I-CCa in liver explants of adult cirrhotic patients undergoing liver transplantation (LT). From December 1985 to November 2008, a first LT was performed in 993 adult cirrhotic patients in three French academic Hospitals. All liver explants were analyzed for the presence of nodules. The diagnosis of HCC was made in 331 cases (33.3% of the patients). Similarly, an I-CCa was identified in 10 (1%) patients, with a mean size of 31 ± 17 mm. The mean age at transplantation was 58.8 yr (range 45 - 66), and all the patients were men. The mean follow-up after LT was 33 months (range 4-52). Post-transplant tumor recurrence was observed in five patients (50%), after a mean delay of 10 months. All five patients died. Malignant recurrence was associated with the presence of venous emboli on liver explants. Our results suggest that unrecognized I-CCa complicating liver cirrhosis is a rare entity, associated with high risk of recurrence and poor prognosis.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2013        PMID: 23438040     DOI: 10.1111/ctr.12108

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  10 in total

Review 1.  Liver transplantation for cholangiocarcinoma: Current status and new insights.

Authors:  Gonzalo Sapisochín; Elena Fernández de Sevilla; Juan Echeverri; Ramón Charco
Journal:  World J Hepatol       Date:  2015-10-08

2.  Liver transplantation for the solitary intrahepatic cholangiocarcinoma less than 2 cm in diameter.

Authors:  Nobuhisa Akamatsu; Yoshihiro Sakamoto; Kiyoshi Hasegawa
Journal:  Hepatobiliary Surg Nutr       Date:  2017-10       Impact factor: 7.293

Review 3.  Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.

Authors:  Rahul Gupta; Junichi Togashi; Nobuhisa Akamatsu; Yoshihiro Sakamoto; Norihiro Kokudo
Journal:  Surg Today       Date:  2017-01-25       Impact factor: 2.549

4.  Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.

Authors:  Kellie Young; Nicholas Fidelman; Francis Y Yao; Nancy K Hills; Maureen P Kohi; K Pallav Kolli; Andrew G Taylor; Robert K Kerlan
Journal:  Liver Transpl       Date:  2015-04       Impact factor: 5.799

5.  Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.

Authors:  Ka Wing Ma; Kenneth Siu Ho Chok; Wong Hoi She; Tan To Cheung; Albert Chi Yan Chan; Wing Chiu Dai; James Yan Yue Fung; Chung Mau Lo
Journal:  Hepatol Int       Date:  2018-02-15       Impact factor: 6.047

Review 6.  Contrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD Guideline.

Authors:  Le-Hang Guo; Hui-Xiong Xu
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

7.  Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection.

Authors:  Seogsong Jeong; Lei Gao; Ying Tong; Lei Xia; Ning Xu; Meng Sha; Jianjun Zhang; Xiaoni Kong; Jinyang Gu; Qiang Xia
Journal:  Can J Gastroenterol Hepatol       Date:  2017-11-12

8.  Diagnosis efficacy of CEUS for hepatic inflammatory lesions.

Authors:  Yuanyuan Guo; Xiachuan Qin; Shaoxian Chen; Xuebin Liu; Peng Gu
Journal:  J Clin Lab Anal       Date:  2020-02-03       Impact factor: 2.352

Review 9.  Current status of liver transplantation for cholangiocarcinoma.

Authors:  Patrick Twohig; Thoetchai Bee Peeraphatdit; Sandeep Mukherjee
Journal:  World J Gastrointest Surg       Date:  2022-01-27

Review 10.  Liver Transplantation for Intrahepatic Cholangiocarcinoma: What Are New Insights and What Should We Follow?

Authors:  Dawei Sun; Guoyue Lv; Jiahong Dong
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.